BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asfour HZ, Fahmy UA, Alharbi WS, Almehmady AM, Alamoudi AJ, Tima S, Mansouri RA, Omar UM, Ahmed OAA, Zakai SA, Aldarmahi AA, Bagalagel A, Diri R, Alhakamy NA. Phyto-Phospholipid Conjugated Scorpion Venom Nanovesicles as Promising Carrier That Improves Efficacy of Thymoquinone against Adenocarcinoma Human Alveolar Basal Epithelial Cells. Pharmaceutics 2021;13:2144. [PMID: 34959424 DOI: 10.3390/pharmaceutics13122144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Huang L, Kim M, Cho JY. The Role of Thymoquinone in Inflammatory Response in Chronic Diseases. IJMS 2022;23:10246. [DOI: 10.3390/ijms231810246] [Reference Citation Analysis]
2 Ahmed OAA, Badr-Eldin SM, Caruso G, Fahmy UA, Alharbi WS, Almehmady AM, Alghamdi SA, Alhakamy NA, Mohamed AI, Aldawsari HM, Mady FM. Colon targeted Eudragit coated beads loaded with optimized fluvastatin-scorpion venom conjugate as a potential approach for colon cancer therapy: in vitro anticancer activity and in vivo colon imaging. J Pharm Sci 2022:S0022-3549(22)00354-9. [PMID: 36007556 DOI: 10.1016/j.xphs.2022.08.020] [Reference Citation Analysis]
3 Saddiq AA, El-far AH, Mohamed Abdullah SA, Godugu K, Almaghrabi OA, Mousa SA. Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression. Front Pharmacol 2022;13:936996. [DOI: 10.3389/fphar.2022.936996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]